The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Nephrotoxicity of Iso-osmolar Iodixanol Compared with Nonionic Low-osmolar Contrast Media: Meta-analysis of Randomized Controlled Trials
Abstract
PURPOSE: To compare the nephrotoxicity of iso-osmolar iodixanol with that of nonionic low-osmolar contrast media (CM) (LOCM) in randomized clinical trials. MATERIALS AND METHODS: This meta-analysis was conducted with a systematic search of MEDLINE, EMBASE, BIOSIS, Web of Science, ISI Web of Knowledge, Current Contents Medizin, Cochrane Library (until August 2007), trial registers, conference proceedings, and reference lists to identify studies and with requests from all manufacturers of CM for unidentified studies. Randomized controlled trials assessing serum creatinine levels before and after intravascular application of iodixanol or LOCM were included. The primary outcome measures were the incidence of contrast medium-induced nephropathy (CIN) and change in serum creatinine levels. RESULTS: Twenty-five trials were included. Iodixanol did not significantly reduce the risk of CIN (relative risk [RR], 0.80; 95% confidence interval [CI]: 0.61, 1.04; weighted mean difference in serum creatinine increase, 0.01 mg/dL [0.88 mumol/L]; 95% CI: -0.01, 0.03). There was no significant risk reduction after intravenous administration of the CM (RR, 1.08; 95% CI: 0.62, 1.89); subgroup with preexisting renal insufficiency (RR, 1.07; 95% CI: 0.56, 2.02) or after intraarterial administration (RR, 0.68; 95% CI: 0.46, 1.01); subgroup with preexisting renal insufficiency (RR, 0.59; 95% CI: 0.33, 1.07). However, in patients with intraarterial administration and renal insufficiency, the risk of CIN was greater for iohexol than for iodixanol (RR, 0.38; 95% CI: 0.21, 0.68), whereas there was no difference between iodixanol and the other (noniohexol) LOCM (RR, 0.95; 95% CI: 0.50, 1.78). CONCLUSION: Iodixanol is not associated with a significantly reduced risk of CIN compared with the LOCM pooled together. However, in patients with intraarterial administration and renal insufficiency, iodixanol is associated with a reduced risk of CIN compared with iohexol, whereas no significant difference between iodixanol and other LOCM could be found.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139
Bias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552
Assessing the quality of reports of randomized clinical trials: Is blinding necessary?
Jadad, A. R., Moore, R. A., Carroll, D., Jenkinson, C., Reynolds, D. J. M., Gavaghan, D. J., & McQuay, H. J. (1996) · Controlled Clinical Trials · doi:10.1016/0197-2456(95)00134-4 · Cited by 17,582
Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
Moher, D., Pham, B., Jones, A., Cook, D. J., Jadad, A. R., Moher, M., Tugwell, P., & Klassen, T. P. (1998) · The Lancet · doi:10.1016/s0140-6736(98)01085-x · Cited by 3,560
How should meta‐regression analyses be undertaken and interpreted?
Thompson, S. G., & Higgins, J. P. T. (2002) · Statistics in Medicine · doi:10.1002/sim.1187 · Cited by 3,026
Hospital-acquired renal insufficiency
Nash, K., Hafeez, A., & Hou, S. (2002) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2002.32766 · Cited by 1,951
Anderson, J. L., Adams, C. D., Antman, E. M., Bridges, C. R., Califf, R. M., Casey, D. E., Chavey, W. E., Fesmire, F. M., Hochman, J. S., Levin, T. N., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.181940 · Cited by 1,853
Incidence and Prognostic Importance of Acute Renal Failure After Percutaneous Coronary Intervention
Rihal, C. S., Textor, S. C., Grill, D. E., Berger, P. B., Ting, H. H., Best, P. J., Singh, M., Bell, M. R., Barsness, G. W., Mathew, V., et al. (2002) · Circulation · doi:10.1161/01.cir.0000016043.87291.33 · Cited by 1,712
Acute Renal Failure After Coronary Intervention
McCullough, P. A., Wolyn, R., Rocher, L. L., Levin, R. N., & O’Neill, W. W. (1997) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)00150-2 · Cited by 1,671
The effect of acute renal failure on mortality. A cohort analysis
Levy, E. M. (1996) · JAMA · doi:10.1001/jama.275.19.1489 · Cited by 1,660
Nephrotoxic Effects in High-Risk Patients Undergoing Angiography
Aspelin, P., Aubry, P., Fransson, S.-G., Strasser, R., Willenbrock, R., & Berg, K. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021833 · Cited by 1,136
Parfrey, P. S., Griffiths, S. M., Barrett, B. J., Paul, M. D., Genge, M., Withers, J., Farid, N., & McManamon, P. J. (1989) · New England Journal of Medicine · doi:10.1056/nejm198901193200303 · Cited by 1,011
Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: A randomized trial
Rudnick, M. R., Goldfarb, S., Wexler, L., Ludbrook, P. A., Murphy, M. J., Halpern, E. F., Hill, J. A., Winniford, M., Cohen, M. B., VanFossen, D. B., et al. (1995) · Kidney International · doi:10.1038/ki.1995.32 · Cited by 923
Marenzi, G., Lauri, G., Assanelli, E., Campodonico, J., De Metrio, M., Marana, I., Grazi, M., Veglia, F., & Bartorelli, A. L. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.07.043 · Cited by 737
Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media.
Barrett, B. J., & Carlisle, E. J. (1993) · Radiology · doi:10.1148/radiology.188.1.8511292 · Cited by 727
N -Acetylcysteine and Contrast-Induced Nephropathy in Primary Angioplasty
Marenzi, G., Assanelli, E., Marana, I., Lauri, G., Campodonico, J., Grazi, M., De Metrio, M., Galli, S., Fabbiocchi, F., Montorsi, P., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054209 · Cited by 611
Dangas, G., Iakovou, I., Nikolsky, E., Aymong, E. D., Mintz, G. S., Kipshidze, N. N., Lansky, A. J., Moussa, I., Stone, G. W., Moses, J. W., et al. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.08.056 · Cited by 597
Preventing Nephropathy Induced by Contrast Medium
Barrett, B. J., & Parfrey, P. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmcp050801 · Cited by 597
Meta-analysis: Effectiveness of Drugs for Preventing Contrast-Induced Nephropathy
Kelly, A. M., Dwamena, B., Cronin, P., Bernstein, S. J., & Carlos, R. C. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-4-200802190-00007 · Cited by 435
Prophylaxis Strategies for Contrast-Induced Nephropathy
Pannu, N., Wiebe, N., Tonelli, M., & Alberta Kidney Disease Network, F. T. (2006) · JAMA · doi:10.1001/jama.295.23.2765 · Cited by 410
Solomon, R. J., Natarajan, M. K., Doucet, S., Sharma, S. K., Staniloae, C. S., Katholi, R. E., Gelormini, J. L., Labinaz, M., Moreyra, A. E., & the Investigators of the CARE Study (2007) · Circulation · doi:10.1161/circulationaha.106.671644 · Cited by 346
Contrast-induced nephrotoxicity: Clinical landscape
Katzberg, R. W., & Haller, C. (2006) · Kidney International · doi:10.1038/sj.ki.5000366 · Cited by 224
Solomon, R. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00684.x · Cited by 209
Comparison of iodixanol and iohexol in renal impairment.
Chalmers, N., & Jackson, R. W. (1999) · British Journal of Radiology · doi:10.1259/bjr.72.859.10624328 · Cited by 205
Acetylcysteine in the Prevention of Contrast-Induced Nephropathy
Bagshaw, S. M., McAlister, F. A., Manns, B., & Ghali, W. A. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.2.161 · Cited by 132
Iodixanol in Cardioangiography in Patients with Coronary Artery Disease
Kløw, N., Levorstad, K., Berg, K. J., Brodahl, U., Endresen, K., Kristoffersen, D. T., Laake, B., Simonsen, S., Tofte, A. J., & Lundby, B. (1993) · Acta Radiologica · doi:10.1080/02841859309173240 · Cited by 66
Iodixanol in Femoral Arteriography
Thorstensen, O., Albrechtsson, U., Calissendorff, B., et al. (1994) · Acta Radiologica · doi:10.1080/02841859409173335 · Cited by 15
Iodixanol in Femoral Arteriography
Thorstensen, O., Albrechtsson, U., Calissendorff, B., et al. (1994) · Acta Radiologica · doi:10.1177/028418519403500622 · Cited by 12
Cited by
Writing Committee Members, Levine, G. N., Bates, E. R., Blankenship, J. C., Bailey, S. R., Bittl, J. A., Cercek, B., Chambers, C. E., Ellis, S. G., Guyton, R. A., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31823ba622 · Cited by 3,289
2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention
Levine, G. N., Bates, E. R., Blankenship, J. C., Bailey, S. R., Bittl, J. A., Cercek, B., Chambers, C. E., Ellis, S. G., Guyton, R. A., Hollenberg, S. M., et al. (2011) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2011.08.007 · Cited by 2,164
Kushner, F. G., Hand, M., Smith, S. C., King, S. B., Anderson, J. L., Antman, E. M., Bailey, S. R., Bates, E. R., Blankenship, J. C., Casey, D. E., et al. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.10.015 · Cited by 1,911
Kushner, F. G., Hand, M., Smith, S. C., King, S. B., Anderson, J. L., Antman, E. M., Bailey, S. R., Bates, E. R., Blankenship, J. C., Casey, D. E., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192663 · Cited by 1,700
Contrast Medium-Induced Acute Kidney Injury
Sadat, U., Usman, A., Boyle, J. R., Hayes, P. D., & Solomon, R. J. (2015) · Cardiorenal Medicine · doi:10.1159/000430770 · Cited by 1,285
Metadata
- Authors
- Heinrich, M. C., Häberle, L., Müller, V., Bautz, W., & Uder, M.
- Venue
- Radiology
- Published
- 2009-01
- Volume
- 250
- Issue
- 1
- Pages
- 68-86
- ISSN
- 0033-8419 (ISSN-L)
- 1527-1315
- OpenAlex
- W2107670692
- Cited by
- 319
- References
- 30
- FWCI
- 3.52
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.